Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 439-441

  Chen, Iris ^a   Kaufisi, Pakieli ^a   Erdem, Guliz ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; HEALTH SURVEY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; HAWAII; HUMANS; MOLECULAR TYPING; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; STREPTOGRAMIN B; TRANSCRIPTIONAL ACTIVATION;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 78650913882     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02208-10     Document Type: Article

References (31)

1. Barrozo, C. P., K. L. Russell, T. C. Smith, A. W. Hawksworth, M. A. Ryan, and G. C. Gray. 2003. National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites. J. Clin. Microbiol. 41:4808-4811.
2. CLSI. 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically for streptococcus spp. beta-hemolytic group: approved standard, 7th ed. CLSI, Wayne, PA.
3. CLSI. 2008. Performance standards for antimicrobial disk susceptibility tests for streptococcus spp. beta-hemolytic group: approved standard, 9th ed. CLSI, Wayne, PA.
4. Dicuonzo, G., E. Fiscarelli, G. Gherardi, G. Lorino, F. Battistoni, S. Landi, M. De Cesaris, T. Petitti, and B. Beall. 2002. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob. Agents Chemother. 46:3987-3990.
5. Erdem, G., L. Abe, R. Y. Kanenaka, L. Pang, K. Mills, C. Mizumoto, K. Yamaga, and P. V. Effler. 2004. Characterization of a community cluster of group A streptococcal invasive disease in Maui, Hawaii. Pediatr. Infect. Dis. J. 23:677-679.
6. Erdem, G., J. Ford, D. Johnson, L. Abe, K. Yamaga, and E. Kaplan. 2005. Erythromycin-resistant group A streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types. J. Clin. Microbiol. 43:2497-2499.
7. Erdem, G., J. M. Ford, R. Y. Kanenaka, L. Abe, K. Yamaga, and P. V. Effler. 2005. Molecular epidemiologic comparison of 2 unusual clusters of group A streptococcal necrotizing fasciitis in Hawaii. Clin. Infect. Dis. 40:1851-1854.
8. Erdem, G., C. Mizumoto, D. Esaki, L. Abe, V. Reddy, and P. V. Effler. 2009. Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr. Infect. Dis. J. 28:13-16.
9. Erdem, G., C. Mizumoto, D. Esaki, V. Reddy, D. Kurahara, K. Yamaga, L. Abe, D. Johnson, K. Yamamoto, and E. L. Kaplan. 2007. Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin. Infect. Dis. 45:e20-e24.
10. Erdem, G., S. Sinclair, J. R. Marrone, T. F. I'Atala, A. Tuua, B. Tuua, F. Tuumua, A. Dodd, C. Mizumoto, and L. Medina. 2009. Higher rates of streptococcal colonization among children in the Pacific Rim Region correlates with higher rates of group A streptococcal disease and sequelae. Clin. Microbiol. Infect. 16:452-455.
11. Facinelli, B., C. Spinaci, G. Magi, E. Giovanetti, and E. P. Varaldo. 2001. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358:30-33.
12. Fines, M., M. Gueudin, A. Ramon, and R. Leclercq. 2001. In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin. J. Antimicrob. Chemother. 48:411-416.
13. Giovanetti, E., G. Magi, A. Brenciani, C. Spinaci, R. Lupidi, B. Facinelli, and P. E. Varaldo. 2002. Conjugative transfer of the erm(A) gene from erythromycin- resistant Streptococcus pyogenes to macrolide-susceptible S. pyogenes, Enterococcus faecalis and Listeria innocua. J. Antimicrob. Chemother. 50: 249-252.
14. Green, M., J. M. Martin, K. A. Barbadora, B. Beall, and E. R. Wald. 2004. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania. Antimicrob. Agents Chemother. 48:473-476.
15. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
16. Leclercq, R., and P. Courvalin. 2002. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:2727-2734.
17. Malhotra-Kumar, S., A. Mazzariol, L. Van Heirstraeten, C. Lammens, P. de Rijk, G. Cornaglia, and H. Goossens. 2009. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A). J. Antimicrob. Chemother. 63:42-46.
18. Malhotra-Kumar, S., L. Van Heirstraeten, C. Lammens, S. Chapelle, and H. Goossens. 2009. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with cipro- floxacin, levofloxacin and moxifloxacin. J. Antimicrob. Chemother. 63:886-894.
19. Martin, J. M., M. Green, K. A. Barbadora, and E. R. Wald. 2002. Erythromycin- resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346:1200-1206.
20. Morosini, M. I., R. Canton, E. Loza, R. del Campo, F. Almaraz, and F. Baquero. 2003. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin. J. Antimicrob. Chemother. 52:50-55.
21. Neeman, R., N. Keller, A. Barzilai, Z. Korenman, and S. Sela. 1998. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 352:1974-1977.
22. O'Brien, K. L., B. Beall, N. L. Barrett, P. R. Cieslak, A. Reingold, M. M. Farley, R. Danila, E. R. Zell, R. Facklam, B. Schwartz, and A. Schuchat. 2002. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:268-276.
23. Oster, P., A. Zanchi, S. Cresti, M. Lattanzi, F. Montagnani, C. Cellesi, and G. M. Rossolini. 1999. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43:2510-2512.
24. Perez-Trallero, E., J. M. Marimon, M. Montes, B. Orden, and M. de Pablos. 1999. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg. Infect. Dis. 5:235-240.
25. Pournaras, S., A. Efstratiou, J. Douboyas, R. C. George, and A. Tsakris. 2000. Genetic relatedness of group A streptococci of the newly designated serotype M90 causing a food-borne outbreak and sporadic infections. Epidemiol. Infect. 125:299-301.
26. Reinert, R. R., R. Lutticken, J. A. Sutcliffe, A. Tait-Kamradt, M. Y. Cil, H. M. Schorn, A. Bryskier, and A. Al-Lahham. 2004. Clonal relatedness of erythromycin- resistant Streptococcus pyogenes isolates in Germany. Antimicrob. Agents Chemother. 48:1369-1373.
27. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, A. L. Miller, C. L. Rice, C. D. Doern, S. D. Reid, and G. V. Doern. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
28. Robinson, D. A., J. A. Sutcliffe, W. Tewodros, A. Manoharan, and D. E. Bessen. 2006. Evolution and global dissemination of macrolide-resistant group A streptococci. Antimicrob. Agents Chemother. 50:2903-2911.
29. Steer, A. C., I. Law, L. Matatolu, B. W. Beall, and J. R. Carapetis. 2009. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9:611-616.
30. Tanz, R. R., S. T. Shulman, V. D. Shortridge, W. Kabat, K. Kabat, E. Cederlund, J. Rippe, J. Beyer, S. Doktor, and B. W. Beall. 2004. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin. Infect. Dis. 39:1794-1801.
31. Zimbelman, J., A. Palmer, and J. Todd. 1999. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr. Infect. Dis. J. 18:1096-1100.